Anti-PD‑1-induced type 1 diabetes mellitus in patient with recurrent oropharyngeal squamous cell cancer

Author:

Lianova A. A.1ORCID,Vladimirova L. Yu.1ORCID,Abramova N. A.1ORCID,Teplyakova M. A.1ORCID,Popova I. L.1ORCID,Tikhanovskaya N. M.1ORCID,Storozhakova A. E.1ORCID,Ryadinskaya L. A.1ORCID,Udalenkova I. A.1ORCID,Kalabanova E. A.1ORCID,Trifanov D.2ORCID

Affiliation:

1. National Medical Research Centre of Oncology

2. Christiana Care Hospital

Publisher

Alfmed LLC

Subject

Materials Chemistry,Economics and Econometrics,Media Technology,Forestry

Reference44 articles.

1. Kotwal A, Haddox C, Block M, Kudva YC. Immune checkpoint inhibitors: an emerging cause of insulin-dependent diabetes. BMJ Open Diabetes Res Care. 2019 Feb 13; 7 (1): e000591. PMID: 30899528; PMCID: PMC6398813. DOI: 10.1136/bmjdrc‑2018–000591.

2. Yang Y. Cancer immunotherapy: Harnessing the immune system to battle cancer. J Clin Invest. 2015 Sep; 125 (9): 3335–7. Epub 2015 Sep 1. PMID: 26325031; PMCID: PMC4588312. DOI: 10.1172/JCI83871.

3. Drake CG, Jaffee E, Pardoll DM. Mechanisms of immune evasion by tumors. Adv Immunol. 2006; 90: 51–81.

4. Владимирова Л.Ю., Сторожакова А.Э., Попова И.Л., Кабанов С.Н., Абрамова Н.А., Теплякова М.А., Тихановская Н.М., Новоселова К.А., Льянова А.А., Рядинская Л.А., Мягкова В. С., Алиева Ф. В., Калабанова Е. А., Светицкая Я. В., Саманева Н.Ю., Тишина А.В. Некоторые аспекты применения ниволумаба в лечении метастатической меланомы (клинические наблюдения). Медицинский совет. 2021; (9): 64–74. https://doi.org/10.21518/2079–701X‑2021–9–64–74

5. Vladimirova L. Yu., Storozhakova A. E., Popova I. L., Kabanov S.N., Abramova N.A., Teplyakova M.A., Tikhanovskaya N.M., Novoselova K.A., Lyanova A.A., Ryadinskaya L.A., Myagkova V.S., Alieva F.V., Kalabanova E.A., Svetitskaya Ya.V., Samaneva N. Yu., Tishina A.V. Some aspects of the use of nivolumab in the treatment of metastatic melanoma (clinical observations). Medical Advice. 2021; (9): 64–74. https://doi. org/10.21518/2079–701X‑2021–9–64–74

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3